Your browser doesn't support javascript.
loading
Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries.
Garay, Ricardo P; Citrome, Leslie; Samalin, Ludovic; Liu, Chen-Chung; Thomsen, Morten S; Correll, Christoph U; Hameg, Ahcène; Llorca, Pierre-Michel.
Afiliação
  • Garay RP; a INSERM U999, Université Paris-Sud et Hôpital Marie Lannelongue , Le Plessis -Robinson , France.
  • Citrome L; b Pharmacology and Therapeutics, Craven , Villemoisson-sur-Orge , France.
  • Samalin L; c Department of Psychiatry and Behavioral Sciences , New York Medical College , Valhalla , NY , USA.
  • Liu CC; d Centre Médico-Psychologique B , CHU, Clermont-Ferrand, EA U7280, Université d'Auvergne , Clermont-Ferrand , France.
  • Thomsen MS; e Department of Psychiatry , National Taiwan University Hospital , Taipei , Taiwan.
  • Correll CU; f Department of Drug Design & Pharmacology , University of Copenhagen , Copenhagen , Denmark.
  • Hameg A; g The Zucker Hillside Hospital , Psychiatry Research, North Shore - Long Island Jewish Health System , Glen Oaks , NY , USA.
  • Llorca PM; h Hofstra North Shore LIJ School of Medicine , Hempstead , NY , USA.
Expert Opin Pharmacother ; 17(7): 921-36, 2016.
Article em En | MEDLINE | ID: mdl-26831200

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Antipsicóticos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Antipsicóticos Idioma: En Ano de publicação: 2016 Tipo de documento: Article